SCLXW
Scilex Holding CompanyNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
1.42
52W High
$0.65
52W Low
$0.04
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Scilex Holding Company
Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid therapies for patients with acute and chronic pain. The company is headquartered in Palo Alto, California.
Fundamentals
| Revenue (TTM) | $30.25M |
| Gross Profit (TTM) | $19.65M |
| EBITDA | $-267.68M |
| Operating Margin | -782.00% |
| Return on Equity | 0.00% |
| Return on Assets | -74.30% |
| Revenue/Share (TTM) | $2.74 |
| Book Value | $-29.54 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -67.80% |
| Shares Outstanding | 0 |
| Float | $4.71M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Data last updated: 5/2/2026